EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Reply: Interleukin-18 Inhibition in Inflammatory Bowel Diseases: A Delicate Balance

Keiko Maeda iD, Hiroki Kawashima

Inflammatory Bowel Diseases · 03.04.2024 · 30 (4) · 695-696

DOI: 10.1093/ibd/izae039 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 05.03.2024. Verfasst von Keiko Maeda und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Colitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesColitisAnimalsMiceAntibodies, MonoclonalInterleukin-18

Substanzen

Antibodies, MonoclonalInterleukin-18

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.

ORCID-Profile: Keiko Maeda

Zitieren

APA

Maeda, K., & Kawashima, H. (2024). Reply: Interleukin-18 Inhibition in Inflammatory Bowel Diseases: A Delicate Balance. Inflammatory Bowel Diseases, 30(4), 695-696. https://doi.org/10.1093/ibd/izae039

Vancouver

Maeda K, Kawashima H. Reply: Interleukin-18 Inhibition in Inflammatory Bowel Diseases: A Delicate Balance. Inflammatory Bowel Diseases. 2024;30(4):695-696. doi:10.1093/ibd/izae039

BibTeX
@article{Maeda2024,
  author = {Maeda, Keiko and Kawashima, Hiroki},
  title = {Reply: Interleukin-18 Inhibition in Inflammatory Bowel Diseases: A Delicate Balance},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  volume = {30},
  number = {4},
  pages = {695--696},
  doi = {10.1093/ibd/izae039}
}
Kostenlos starten →